APOE and Cognitive impairment: As clinical deterioration can be detected as measurable cognitive impairment around two decades before the onset of dementia in PSEN1 E280A carriers, our findings could potentially serve as a model for exploring the complex interaction between PSEN1 variants and the APOE genotype in microglia in relation to neuron-secreted Aβ.